Prophylaxis of bipolar disorder: how and who should we treat in the long term?
- 31 August 1999
- journal article
- review article
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 9, S125-S129
- https://doi.org/10.1016/s0924-977x(99)00026-7
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Lamotrigine and the treatment of mania in bipolar disorderEuropean Neuropsychopharmacology, 1999
- Lamotrigine in the treatment of bipolar depressionEuropean Neuropsychopharmacology, 1999
- A Double-Blind Placebo-Controlled Study of Lamotrigine Monotherapy in Outpatients With Bipolar I DepressionThe Journal of Clinical Psychiatry, 1999
- Clinical Studies on the Use of Lamotrigine in Bipolar DisorderNeuropsychobiology, 1998
- New Concepts in Mood Stabilization: Evidence for the Effectiveness of Valproate and LamotrigineNeuropsychopharmacology, 1998
- Lithium: balancing risks and benefitsThe British Journal of Psychiatry, 1997
- Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study GroupPublished by American Medical Association (AMA) ,1994
- Carbamazepine versus lithium in the prophylaxis of bipolar affective disorderActa Psychiatrica Scandinavica, 1992
- The Syndrome of Irreversible Lithium-Effectuated Neurotoxicity (SILENT)Pharmacopsychiatry, 1989
- Does maintenance lithium therapy prevent recurrences of mania under ordinary clinical conditions?Psychological Medicine, 1986